Question 1

What is the catalog number for Orelabrutinib (ICP-022)?

Accepted Answer

The catalog number for Orelabrutinib (ICP-022) is B2789-1.

Question 2

Is Orelabrutinib (ICP-022) in stock?

Accepted Answer

Orelabrutinib (ICP-022) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 3

What is Orelabrutinib (ICP-022) used for?

Accepted Answer

Orelabrutinib is a potent and irreversible Bruton's tyrosine kinase (BTK) inhibitor with potential antineoplastic activity. Orelabrutinib prevents both the activation of the B-cell antigen receptor (BCR) signaling pathway and BTK-mediated activation of downstream survival pathways, inhibiting the gr

Question 4

Is this kit compatible with automated liquid handling platforms?

Accepted Answer

Automation compatibility varies by kit and isn’t always listed on the datasheet. Contact our technical support team with details of your platform so we can confirm with the manufacturer.

Question 5

What applications has this product been validated for?

Accepted Answer

Validated applications such as WB, ELISA, IHC, ICC, or FC are listed on the product datasheet. If you need application-specific validation data before ordering, contact our technical support team with the catalogue number.

Question 6

How do I reconstitute this lyophilized product?

Accepted Answer

Reconstitution instructions, including the recommended diluent and final concentration, are provided on the datasheet. Aliquot immediately after reconstitution to avoid repeated freeze-thaw cycles.

Orelabrutinib (ICP-022)

Product Specifications

Shipping Conditions

Storage Conditions

Shelf Life

Frequently Asked Questions

Explore Other Products

CD3e (CRIS-7), CF647 conjugate, 0.1mg/mL

MAGE A1 (MA454), CF647 conjugate, 0.1mg/mL

CD46 (122.2), CF647 conjugate, 0.1mg/mL

CD71 (66IG10), CF647 conjugate, 0.1mg/mL

Mucin 5AC (MUC5AC) (58M1), CF647 conjugate, 0.1mg/mL

CD63 (MX-49.129.5), CF594 conjugate, 0.1mg/mL